Claspin Overexpression Promotes Tumor Progression and Predicts Poor Clinical Outcome in Prostate Cancer

2021 ◽  
Vol 25 (2) ◽  
pp. 131-139 ◽  
Author(s):  
Chao Cai ◽  
Jiexin Luo ◽  
Qinwei Liu ◽  
Zezhen Liu ◽  
Yan Zhao ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Outcome ◽  
Tumor Progression ◽  
Poor Clinical Outcome

scholarly journals COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer

Oncogene ◽  
2013 ◽  
Vol 33 (26) ◽  
pp. 3432-3440 ◽  
Author(s):  
Y-H Wu ◽  
T-H Chang ◽  
Y-F Huang ◽  
H-D Huang ◽  
C-Y Chou
Keyword(s):  
Ovarian Cancer ◽  
Clinical Outcome ◽  
Tumor Progression ◽  
Poor Clinical Outcome

scholarly journals High expression of atonal homolog 8 predicts a poor clinical outcome in patients with colorectal cancer and contributes to tumor progression

2017 ◽  
Vol 37 (5) ◽  
pp. 2955-2963 ◽  
Author(s):  
Mengsi Ye ◽  
Yun He ◽  
Hao Lin ◽  
Shouxing Yang ◽  
Yuhui Zhou ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Clinical Outcome ◽  
Tumor Progression ◽  
High Expression ◽  
Poor Clinical Outcome

Phosphorylation of Akt (Ser473) is an Excellent Predictor of Poor Clinical Outcome in Prostate Cancer

2004 ◽  
Vol 64 (15) ◽  
pp. 5232-5236 ◽  
Author(s):  
Jeffrey I. Kreisberg ◽  
Shazli N. Malik ◽  
Thomas J. Prihoda ◽  
Roble G. Bedolla ◽  
Dean A. Troyer ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Outcome ◽  
Poor Clinical Outcome

scholarly journals MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma

Hepatology ◽  
2016 ◽  
Vol 63 (4) ◽  
pp. 1227-1239 ◽  
Author(s):  
Han-Yue OuYang ◽  
Jing Xu ◽  
Jun Luo ◽  
Ru-Hai Zou ◽  
Keng Chen ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Outcome ◽  
Tumor Progression ◽  
Human Hepatocellular Carcinoma ◽  
Poor Clinical Outcome
Sign in / Sign up

Export Citation Format

Share Document